title: Fatal myocardial infarction during nilotinib treatment in a 60-year-old male patient.
authors.forename: Yolanda B
authors.initials: YB
authors.lastname: Brauchli
authors.forename: Thomas
authors.initials: T
authors.lastname: Wais
authors.forename: Alois
authors.initials: A
authors.lastname: Gratwohl
authors.forename: Dominik
authors.initials: D
authors.lastname: Heim
authors.forename: Alexander
authors.initials: A
authors.lastname: Schipf
authors.forename: Joachim
authors.initials: J
authors.lastname: Diebold
authors.forename: Stephan
authors.initials: S
authors.lastname: Krähenbühl
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001344:Autopsy; D003324:Coronary Artery Disease / Q000150:complications*; D004562:Electrocardiography; D005080:Exercise Test; D017809:Fatal Outcome; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000209:etiology / Q000503:physiopathology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C498826:nilotinib